SCHEMBL4918262

SCHEMBL4918262

Cc1ccc(-n2c(C(=O)O)cc3cc(Oc4ccc(Cl)cc4)ccc32)cc1[N+](=O)[O-]

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 1/20 0.41
LMNA P02545 2/20 0.41
HSP90AA1 P07900 1/20 0.40
TSHR P16473 1/20 0.39
CCR2 P41597 4/20 0.39
PTGES O14684 2/20 0.38
TDP1 Q9NUW8 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
GAA P10253 2/20 0.36
GALR3 O60755 1/20 0.36
USP14 P54578 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4912689 0.93 GFER (0.41) GFERLMNAHSP90AA1TSHRCCR2
SCHEMBL4920914 0.92 GFER (0.46) GFERLMNATSHRCCR2PTGES
SCHEMBL4917269 0.91 CCR2 (0.42) GFERTSHRCCR2PTGESTDP1
SCHEMBL4925957 0.83 GFER (0.44) GFERTSHRPTGESGAAGALR3
SCHEMBL4926095 0.83 GFER (0.44) GFERPTGESTDP1MEN1KMT2A
SCHEMBL4922886 0.81 LGALS8 (0.39) GFERLMNATDP1ALDH1A1HPGD
SCHEMBL5266420 0.79 ALDH1A1 (0.58) LMNATSHRCCR2SMN1; SMN2ALDH1A1
SCHEMBL4914078 0.77 PTGES (0.61) GFERTSHRCCR2PTGESSMN1; SMN2
SCHEMBL3574704 0.75 PTGES (0.59) LMNATSHRPTGESTDP1SMN1; SMN2
SCHEMBL4925290 0.72 MAPT (0.49) HSP90AA1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249091-A1 Indoles Useful in the Treatment of Inflammation BIOLIPOX AB (SE) 2008-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249091-A1 Indoles Useful in the Treatment of Inflammation IDO1, IDO2, ARG1 GFER 3076/4885LMNA 3599/4885HSP90AA1 2608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.